TABLE 1

Groups Randomized to Paroxetine or Placebo with at Least Four Treatment Sessions.

	>4 sessions^*n = 333		Paroxetinen = 152		Placebon = 181
	No.	Percent	No.	Percent	No.	Percent
Demographics
Sex (female)	172	52	73	48	99	55
Age cohort >59 y	211	63	95	62	116	64
Ethnicity (majority)	271	81	126	83	143	80
Married	178	54	78	51	100	55
Employed	124	37	58	38	66	36
Income, y <$20,000	162	49	79	52	83	46
Veteran	88	26	41	27	47	26
Minor depression	159	48	71	47	88	49
Education <13 y	156	47	72	47	84	46
	Mean	SD	Mean	SD	Mean	SD
Patient beliefs (PAB)
Biological beliefs	3.2	1.1	3.2	1.0	3.2	1.2
Psychological beliefs	3.7	1.0	3.7	1.0	3.7	1.0
SCL scales
Depression	1.5	0.6	1.5	0.6	1.4	0.7
Somatization	1.0	0.7	1.1	0.7	1.0	0.7
Anxiety	0.9	0.6	0.9	0.6	0.9	0.7
Hostility	0.7	0.7	0.8	0.6	0.7	0.7
Interpersonal sensitivity	1.0	0.7	1.0	0.7	1.0	0.7
SF-36 scales
General health	53.3	22.5	52.2	23.0	54.2	22.1
Physical function	60.3	28.8	58.9	28.4	61.4	29.3
Role physical	38.3	40.1	38.3	40.9	38.2	39.6
Role emotional	34.9	38.0	33.8	37.4	35.9	38.5
Pain	52.2	24.4	52.4	24.4	52.0	24.4
Vitality	32.8	19.4	32.2	19.4	33.2	19.5
Mental health	53.8	17.2	52.8	17.0	54.7	17.3
Social function	58.8	25.0	58.0	26.1	59.4	24.1

* There were no significant differences on any variable between groups randomized to paroxetine and placebo.
PAB = Patient Attitudes and Beliefs Scale, SCL = Hopkins Symptom Checklist-57 scales, SF-36 = Medical Outcomes Study Short-Form 36 Scale.